Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I G Robertson

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Biochemical and Biophysical Research Communications|February 28, 1985
Differences in the occurrence of glutathione transferase isoenzymes in rat lung and liverI G Robertson, H Jensson, C Guthenberg, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Pharmacokinetics and toxicity of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide after i.v. administration in the mouseJ W Paxton, D Young, S M Evans, et al.
Drug Metabolism and Drug Interactions|January 1, 1988
Thiolytic cleavage and binding of the antitumour agent CI-921 in bloodP Kestell, J W Paxton, I G Robertson, et al.
Biochemical Pharmacology|October 24, 1991
Cytosol mediated metabolism of the experimental antitumor agent acridine carboxamide to the 9-acridone derivativeI G Robertson, B D Palmer, M Officer, et al.
Bioelectromagnetics|January 1, 1996
Evaluation of potential health effects of 10 kHz magnetic fields: a short-term mouse toxicology studyI G Robertson, W R Wilson, B V Dawson, et al.
Bioelectromagnetics|April 29, 1998
Evaluation of potential health effects of 10 kHz magnetic fields: a rodent reproductive studyB V Dawson, I G Robertson, W R Wilson, et al.
Biochemical Pharmacology|November 3, 1992
Oxidative metabolism of amsacrine by the neutrophil enzyme myeloperoxidaseA J Kettle, I G Robertson, B D Palmer, et al.
Cancer Research|February 1, 1990
Disposition of amsacrine and its analogue 9-([2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921) in plasma, liver, and Lewis lung tumors in miceP Kestell, J W Paxton, P C Evans, et al.
Cancer Chemotherapy and Pharmacology|June 15, 1999
Metabolism of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in cancer patients undergoing a phase I clinical trialP C Schofield, I G Robertson, J W Paxton, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Biochemical and Biophysical Research Communications|February 28, 1985
Differences in the occurrence of glutathione transferase isoenzymes in rat lung and liverI G Robertson, H Jensson, C Guthenberg, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Pharmacokinetics and toxicity of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide after i.v. administration in the mouseJ W Paxton, D Young, S M Evans, et al.
Drug Metabolism and Drug Interactions|January 1, 1988
Thiolytic cleavage and binding of the antitumour agent CI-921 in bloodP Kestell, J W Paxton, I G Robertson, et al.
Biochemical Pharmacology|October 24, 1991
Cytosol mediated metabolism of the experimental antitumor agent acridine carboxamide to the 9-acridone derivativeI G Robertson, B D Palmer, M Officer, et al.
Bioelectromagnetics|January 1, 1996
Evaluation of potential health effects of 10 kHz magnetic fields: a short-term mouse toxicology studyI G Robertson, W R Wilson, B V Dawson, et al.
Bioelectromagnetics|April 29, 1998
Evaluation of potential health effects of 10 kHz magnetic fields: a rodent reproductive studyB V Dawson, I G Robertson, W R Wilson, et al.
Biochemical Pharmacology|November 3, 1992
Oxidative metabolism of amsacrine by the neutrophil enzyme myeloperoxidaseA J Kettle, I G Robertson, B D Palmer, et al.
Cancer Research|February 1, 1990
Disposition of amsacrine and its analogue 9-([2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921) in plasma, liver, and Lewis lung tumors in miceP Kestell, J W Paxton, P C Evans, et al.
Cancer Chemotherapy and Pharmacology|June 15, 1999
Metabolism of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in cancer patients undergoing a phase I clinical trialP C Schofield, I G Robertson, J W Paxton, et al.
Pageof 4